Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-216-2 | CAS number: 93-08-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- one-generation reproductive toxicity
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- secondary literature
- Justification for type of information:
- Data from secondary source
Data source
Reference
- Reference Type:
- other: secondary source
- Title:
- One generation reproduction developmental toxicity study in Wistar rats
- Author:
- European Food Safety Agency (EFSA)
- Year:
- 2 010
- Bibliographic source:
- Additional Report to the DAR for test material ,2010
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 415 [One-Generation Reproduction Toxicity Study (before 9 October 2017)]
- Principles of method if other than guideline:
- One generation reproductive toxicity study of test material was performed on male and female Wistar rats.
- GLP compliance:
- not specified
- Limit test:
- no
- Justification for study design:
- No data available
Test material
- Reference substance name:
- 2-naphthyloxyacetic acid
- EC Number:
- 204-380-0
- EC Name:
- 2-naphthyloxyacetic acid
- Cas Number:
- 120-23-0
- Molecular formula:
- C12H10O3
- IUPAC Name:
- 2-naphthyloxyacetic acid
- Details on test material:
- - Name of test material: 2-naphthyloxyacetic acid
- Molecular formula: C12H10O3
- Molecular weight: 202.208 g/mol
- Substance type: Organic
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Details on species / strain selection:
- No data available
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- No data available
Administration / exposure
- Route of administration:
- oral: feed
- Type of inhalation exposure (if applicable):
- not specified
- Remarks on MMAD:
- No data available
- Vehicle:
- not specified
- Details on exposure:
- No data available
- Details on mating procedure:
- No data available.
- Analytical verification of doses or concentrations:
- not specified
- Details on analytical verification of doses or concentrations:
- No data available
- Duration of treatment / exposure:
- Males were treated for 10 weeks before mating and during the mated period and females for at least two weeks before mating, during 3 weeks of mating and pregnancy till the 21st day of lactation. The dams were allowed naturally deliver after mating and necropsied with their offspring on the 21st day of lactation.
- Frequency of treatment:
- daily
- Details on study schedule:
- No data available
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day
- Dose / conc.:
- 100 mg/kg bw/day
- Dose / conc.:
- 500 mg/kg bw/day
- Dose / conc.:
- 2 500 mg/kg bw/day
- No. of animals per sex per dose:
- Total:200
0 ppm:25 male and 25 female
100ppm:25 male and 25 female
500ppm:25 male and 25 female
2500 ppm:25 male and 25 female - Control animals:
- yes
- Details on study design:
- No data available
- Positive control:
- No data available
Examinations
- Parental animals: Observations and examinations:
- Parental animals observation and examinations
CAGE SIDE OBSERVATIONS: yes
DETAILED CLINICAL OBSERVATIONS: Yes
Time schedule: daily
BODY WEIGHT: Yes
Time schedule for examinations: Body weights were recorded weekly during gestation period and at days 1, 4, 7, 14 and 21 during lactation period.
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study): Yes Food consumption was measured weekly during experimental period. Food intake was recorded on presumed gestation days 7, 14 and 20 and on lactation days 4, 7, 14, 18 and 21.
Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes
Compound intake calculated as time-weighted averages from the consumption and body weight gain data: Yes / No / No data: No data available
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): No data
Time schedule for examinations - Oestrous cyclicity (parental animals):
- No data available
- Sperm parameters (parental animals):
- Yes, sperm morphology, caunt and motility were recorded.
- Litter observations:
- At birth, the number of pups born, sex and body weight of individual pups on days 1 and 4 were recorded. After standardization of litter size to 8 pups, pups were weighed individually on days 7, 14 and 21 of lactation. On day of weaning sacrifice (day 21), only one randomly selected pup per sex per litter was submitted to macroscopic examination. Fertility index for dams, sires and pup survival index were calculated.
- Postmortem examinations (parental animals):
- SACRIFICE
- Male animals: All surviving males were sacrificed shortly after the 3 weeks of mating period.
- Maternal animals: The dams were sacriced with their offspring on the 21st day of lactation.
GROSS NECROPSY: Yes. The following tissues and organs were preserved in 10% neutral buffered formalin and submitted to microscopic examination: grossly abnormal tissues, ovaries, uterus, vagina, testes, epididymides, seminal vesicles, prostate, coagulating glands, pituitary gland and target organs of all parental animals. The number of corpora lutea and implantation sites were recorded for all the dams.
HISTOPATHOLOGY / ORGAN WEIGHTS: Yes
Histopathological examination of the parents was initially restricted to preserved organs from control and high dose group animals. - Postmortem examinations (offspring):
- SACRIFICE
On day of weaning sacrifice (day 21), only one randomly selected pup per sex per litter was submitted to macroscopic examination. - Statistics:
- All quantitative variables like body weight and feed intake data were analysed by one-way ANOVA. Comparison of means between treatment groups and vehicle control group were done using Dunnett’s test if the overall treatment ‘F’ test was found to be significant. Pre-implantation loss, post implantation loss, number of corpora lutea, implantations, pre-coital interval and litters size (number) were analysed by one-way ANOVA after suitable transformation. Dunnett’s pair-wise comparison of the treated means with the control mean was done if the group differences were found significant. Z test was performed for testing the differences in proportions for mating and fertility indices and survival indices.
- Reproductive indices:
- Yes, Fertility index for male and female animals were calculated.
- Offspring viability indices:
- yes
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- not specified
- Dermal irritation (if dermal study):
- not specified
- Mortality:
- not specified
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- There were significant lower body weights from control at high dose in males from weeks 2 to 6 and at week 8 associated with a significant lower food intake at weeks 2 and 8 at high dose in males. There was also a significant decrease in bodyweights at day 20 of the gestation period in females of the high dose group, also observed at days 4, 7 and 14 of lactation period
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Immunological findings:
- not specified
- Organ weight findings including organ / body weight ratios:
- effects observed, non-treatment-related
- Histopathological findings: non-neoplastic:
- no effects observed
- Description (incidence and severity):
- There were no test item related microscopic changes in males and females. All single or few incidences of microscopic findings observed in males and females were considered as incidental findings.
- Histopathological findings: neoplastic:
- not specified
- Other effects:
- not specified
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- not specified
- Reproductive function: sperm measures:
- no effects observed
- Description (incidence and severity):
- There were no test item related changes in sperm motility, cauda epididymal sperm counts and sperm morphology parameters. However, a statistically significant increase in percentage of abnormal sperms was observed in high dose males but this observed change was within the historical control data. Moreover, no fertility parameters were affected and there were no changes in the testes or epididymis grossly or histopathologically therefore, considered incidental and not related to the treatment.
- Reproductive performance:
- no effects observed
Effect levels (P0)
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- 153.8 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Remarks:
- 2500ppm
- Sex:
- male
- Basis for effect level:
- body weight and weight gain
- food consumption and compound intake
- organ weights and organ / body weight ratios
- gross pathology
- reproductive function (sperm measures)
- reproductive performance
- Remarks on result:
- other: No effects on reproductive performance were observed.
- Dose descriptor:
- NOAEL
- Effect level:
- 393.6 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Remarks:
- 2500 ppm
- Sex:
- female
- Basis for effect level:
- body weight and weight gain
- food consumption and compound intake
- organ weights and organ / body weight ratios
- gross pathology
- reproductive performance
- Remarks on result:
- other: no effects on reproductive performance
- Dose descriptor:
- LOAEL
- Effect level:
- 2 500 ppm (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- body weight and weight gain
- food consumption and compound intake
- Remarks on result:
- other:
- Remarks:
- Significantly reduced bodyweight in the presence of reduced food consumption
Target system / organ toxicity (P0)
- Critical effects observed:
- not specified
- System:
- other: not specified
- Organ:
- not specified
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- not specified
- Dermal irritation (if dermal study):
- not specified
- Mortality / viability:
- no mortality observed
- Description (incidence and severity):
- The mean number of male, female and total pups per litter at all the doses tested were unaffected by treatment
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- The weight of male, female pups per litter at all the doses tested were unaffected by treatment
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Sexual maturation:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- not specified
- Other effects:
- no effects observed
- Description (incidence and severity):
- No treatment-related changes were observed in the data of pups up to lactation day 21 at all the doses tested.
Developmental neurotoxicity (F1)
- Behaviour (functional findings):
- not specified
Developmental immunotoxicity (F1)
- Developmental immunotoxicity:
- not specified
Effect levels (F1)
open allclose all
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- 153.8 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- viability
- mortality
- body weight and weight gain
- gross pathology
- Remarks on result:
- other: No developmental toxic effects were observed
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- 393.6 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- viability
- mortality
- body weight and weight gain
- gross pathology
- Remarks on result:
- other: No developmental toxic effects were observed
Target system / organ toxicity (F1)
- Critical effects observed:
- not specified
- System:
- other: not specified
- Organ:
- not specified
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
- Treatment related:
- not specified
Applicant's summary and conclusion
- Conclusions:
- The No Observed Adverse Effect Level (NOAEL) for maternal and developmental toxicity was considered as 2500 ppm which is equivalent to 153.8 mg/kg body weight/day for males and 393.6 mg/kg body weight/day for females, when male and female Wistar rats were treated with 2-naphthyloxyacetic acid orally over one generation. The LOAEL for systemic toxicity was set as 2500 ppm (153.8 mg/kg body weight/day for males and 393.6 mg/kg body weight/day for females) based on the significant reduction in body weight and food consumption in the high-dose group in both sexes.
- Executive summary:
A one generation reproductive toxicity study of the test chemical was performed according to OECD Guideline 415in male and female Wistar rats. The test material wa smixed in diet at concentrations of0, 100, 500 and 2500 ppm and administered to group of 25 rats/sex/dose group. Males were treated for 10 weeks before mating and during the mated period and females for at least two weeks before mating, during 3 weeks of mating and pregnancy till the 21stday of lactation. The dams were allowed naturally deliver after mating and necropsied with their offspring on the 21stday of lactation.Body weights were recorded weekly during gestation period and at days 1, 4, 7, 14 and 21 during lactation period. Food consumption was measured weekly during experimental period. Food intake was recorded on presumed gestation days 7, 14 and 20 and on lactation days 4, 7, 14, 18 and 21. At birth, the number of pups born, sex and body weight of individual pups on days 1 and 4 were recorded. After standardization of litter size to 8 pups, pups were weighed individually on days 7, 14 and 21 of lactation. On day of weaning sacrifice (day 21), only one randomly selected pup per sex per litter was submitted to macroscopic examination. Fertility index formales and femalesand pupsurvival index were calculated. On completion of the gross pathology examination, the following tissues and organs were preserved in 10% neutral buffered formalin and submitted to microscopic examination: grossly abnormal tissues, ovaries, uterus, vagina, testes, epididymides, seminal vesicles, prostate, coagulating glands, pituitary gland and target organs of allparentalanimals. The number of corpora lutea and implantation sites were recorded for all the dams. Histopathological examination of the parents was initially restricted to preserved organs from control and high dose group animals.There were significant lower body weights from control at high dose (2500 ppm) in males from weeks 2 to 6 and at week 8 associated with a significant lower food intake at weeks 2 and 8 at high dose in males. In females a significant decrease in body weights was observed at day 20 of the gestation period at 2500 ppm group, and at days 4, 7 and 14 of lactation period. A statistically significant increase in relative kidney weights at 500 and 2500 ppm in males and at 2500 ppm for males and females was observed. However, the increased kidney weights observed in males and females were minimal in nature (<12%) and were not associated with microscopic changes, hence considered as toxicologically insignificant changes. The relative weight of epididymides increased significantly at 2500 ppm in males but with no related microscopic changes in left epididymides. Further, there were no corresponding change in the weight of right cauda epididymides and epididymal sperm count, therefore the increased epididymal weights were considered as incidental changes. There were no test item related changes in sperm motility, cauda epididymal sperm counts and sperm morphology parameters. In the 2500 ppm group, a statistically significant increase in percentage of abnormal sperms was observed, although this observed change was within the historical control data. Moreover, no fertility parameters were affected and there were no changes in the testes or epididymis grossly orhistologically.No test chemical-related gross and microscopic changes were found in males and females at any dose groups.The mean number and weight of male, female and total pups per litter at all the doses tested were unaffected by treatment. No treatment-related changes were observed in the data of pups up to lactation day 21 at all the doses tested. As no changes of toxicological significance noted among the rats that received dietary administration of the test chemical over one generation up to the dose level of 2500 ppm which, is equivalent to 153.8 mg/kg body weight/day for males and 393.6 mg/kg body weight/day for females, this dose level is considered to be NOAEL for systemic and reproductive toxicity in parental animals and toxicity to offspring, under the test conditions and doses employed. The LOAEL for systemic toxicity was set as 2500 ppm (153.8 mg/kg body weight/day for males and 393.6 mg/kg body weight/day for females) based on the significant reduction in body weight and food consumption in the high-dose group in both sexes.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.